Structural biology currently plays an important role in the development of novel therapeutic agents including cancer chemotherapies. X-ray crystallography has proved to be a powerful tool for both the discovery of novel compounds and their subsequent development. Understanding the cellular, molecular and biochemical interactions of tumors within their microenvironment is essential to improving cancer diagnosis and treatment.